Phase ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer : Pharmacologic and long-term safety dataMARGOLIN, K; GORDON, M. S; HOLMGREN, E et al.Journal of clinical oncology. 2001, Vol 19, Num 3, pp 851-856, issn 0732-183XArticle

Truncated area under the curve as a measure of relative extent of bioavailability : Evaluation using experimental data and Monte Carlo simulationsGAUDREAULT, J; POTVIN, D; LAVIGNE, J et al.Pharmaceutical research. 1998, Vol 15, Num 10, pp 1621-1629, issn 0724-8741Article

Population pharmacokinetics of terfenadineLALONDE, R. L; LESSARD, D; GAUDREAULT, J et al.Pharmaceutical research. 1996, Vol 13, Num 6, pp 832-838, issn 0724-8741Article

A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnoticBEER, B; IENI, J. R; WEN-HUI WU et al.Journal of clinical pharmacology. 1994, Vol 34, Num 4, pp 335-344, issn 0091-2700Article

Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568LALONDE, R. L; GAUDREAULT, J; KARHU, D. A et al.Clinical pharmacology and therapeutics. 1999, Vol 65, Num 1, pp 40-49, issn 0009-9236Article

Anticonvulsant pharmacodynamics and dispotion of triazolam in ratsGAUDREAULT, J; VARIN, F; POLLACK, G. M et al.Journal of pharmaceutical sciences. 1996, Vol 85, Num 9, pp 999-1004, issn 0022-3549Article

Pharmacokinetics and anticonvulsant effect of a new hypnotic, CL 284,846, in ratsGAUDREAULT, J; VARIN, F; POLLACK, G. M et al.Pharmaceutical research. 1995, Vol 12, Num 11, pp 1592-1597, issn 0724-8741Article